If advertising for participants, investigators must follow these guidelines:

• Information must not be misleading to subjects, especially when a study will involve vulnerable populations
• Include the name and address of the investigator, the purpose of the research and eligibility criteria for participation as subjects, a clear description of any benefits and/or risks of participating, the affiliation of the researcher, the location of the research, and whom to contact for further information
• If a drug or device is to be used in the research, no claim should be made as to its superiority, safety or effectiveness. A copy of the advertisement must be included with the protocol.